DexCom (DXCM) reported Q4 non-GAAP diluted earnings Thursday of $0.45 per share, down from $0.50 a year earlier.
Analysts polled by FactSet expected $0.48.
Revenue for the quarter ended Dec. 31 was $1.11 billion, up from $1.03 billion a year earlier.
Analysts surveyed by FactSet expected $1.11 billion.
The company maintained its full-year 2025 revenue guidance of $4.60 billion.
Analysts polled by FactSet expect $4.61 billion.
免责声明:投资有风险,本文并非投资建议,以上内容不应被视为任何金融产品的购买或出售要约、建议或邀请,作者或其他用户的任何相关讨论、评论或帖子也不应被视为此类内容。本文仅供一般参考,不考虑您的个人投资目标、财务状况或需求。TTM对信息的准确性和完整性不承担任何责任或保证,投资者应自行研究并在投资前寻求专业建议。